Yuko Shirouchi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Multiple Myeloma

Epstein Barr Virus

Diffuse Large B Cell Lymphoma

Top Venues

Leukemia & lymphoma

Japanese journal of clinical oncology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuko Shirouchi, Kazumi Kaihara, Tsunaki Sekita, Naoko Amano, Konosuke Nakayama, Kazunori Miyake, Hitoshi Abe, Hirotoshi Oinuma, Dai Maruyama
Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents. Cancer medicine 13 (16) (2024)
Yuko Shirouchi, Kazumi Kaihara, Tsunaki Sekita, Naoko Amano, Konosuke Nakayama, Kazunori Miyake, Hitoshi Abe, Hirotoshi Oinuma, Dai Maruyama
Impact of M-protein detection on the response evaluations of patients undergoing treatment with the IgG-κ monoclonal antibodies daratumumab or isatuximab, and discrepancies between immunofixation electrophoresis (IFE) systems and reagents. Cancer medicine 13 (16) (2024)
Yuko Shirouchi, Dai Maruyama
Recent advances and future perspectives of T-cell engagers in lymphoid malignancies. Japanese journal of clinical oncology (2024)
Yuko Shirouchi, Dai Maruyama
Recent advances and future perspectives of T-cell engagers in lymphoid malignancies. Japanese journal of clinical oncology 54 (4) (2024)
Yuko Shirouchi, Masahiro Yokoyama, Takanori Fukuta, Hideki Uryu, Noriko Nishimura, Yuko Mishima, Norihito Inoue, Naoko Tsuyama, Kengo Takeuchi, Yasuhito Terui
Progression-free survival at 24 months as a predictor of survival outcomes after CHOP treatment in patients with peripheral T-cell lymphoma: a single-center validation study in a Japanese population. Leukemia & lymphoma 62 (8) (2021)
Hideki Uryu, Yuko Mishima, Naoko Tsuyama, Masahiro Yokoyama, Noriko Nishimura, Takanori Fukuta, Yuko Shirouchi, Takashi Okabe, Norihito Inoue, Kengo Takeuchi, Yasuhito Terui
Rituximab maintenance improves outcomes of transformed diffuse large B-cell lymphoma: a retrospective study of 519 cases with de novo diffuse large B-cell lymphoma and 62 cases with concurrent diffuse large B-cell lymphoma and follicular lymphoma. Leukemia & lymphoma 62 (9) (2021)